Skip header and navigation

24 records – page 1 of 2.

Date Research Question / Title Unique ID Research Team
April 6, 2021 How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals CC210301 RR Critical Care
May 2022 Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR) EOC220301 SBAR EOC
May 19, 2020 Risk estimates for clinical factors predicting severity and/ or mortality associated with COVID-19 EPM050901 RR Table Epidemiology & Modelling
June 10, 2021 What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view? EOC210502 RR EOC
March 18, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001 RR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR Table EOC
June 21, 2021 What are the ethical/legal aspects of vaccine requirements? EOC210503 RR EOC
February 10, 2022 What are the latest health policy definitions of being fully vaccinated? EOC220101 RR Table EOC
February 10, 2022 What are the latest health policy definitions of being fully vaccinated? EOC220101 RR EOC
February 18, 2022 What are the one year outcomes for ICU COVID patients? EOC220201 RR Table EOC
February 18, 2022 What are the one year outcomes for ICU COVID patients? EOC220201 RR EOC
January 13, 2021 What are the outcomes of ECMO and COVID, particularly in small centers? EOC011101 RR EOC
December 9, 2020 What are the predictors of mortality in hospitalized COVID-19 patients? CC120402 RR Critical Care
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR Table EOC
March 12, 2021 What are the vaccination strategies for vulnerable populations? PH030401 RR Public Health
January 15, 2021 What evidence is available to inform vaccination planning in congregate living? EOC011102 RR EOC
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Table Infectious Disease

24 records – page 1 of 2.